Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders-Reference-Cited by-同舟云学术

Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders

Published:2019-12-18 Issue:5 Volume:6 Page:820-831
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Yuan Ying¹,Wang Xiaomei¹,Xu Xiangyi¹,Liu Yu¹^ORCID,Li Cancan²,Yang Meng²,Yang Yiqing³,Ma Zhenkun¹^ORCID

Affiliation:

1. TenNor Therapeutics Limited, 218 Xinghu Street, Suzhou Industrial Park, Suzhou 215123, China

2. WuXi AppTec (Shanghai) Co., Ltd., 288 Fute Zhong Road, Waigaoqiao, China (Shanghai) Pilot Free Trade Zone, Shanghai 200131, China

3. BGI Genomics, BGI Park, No.21 Hongan 3rd Street, Yantian District, Shenzhen 518083, China

Funder

Ministry of Science and Technology of the People's Republic of China

Government of Jiangsu Province

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.9b00374

Reference52 articles.

1. Human gut microbiome: hopes, threats and promises

2. Our gut microbiota: a long walk to homeostasis

3. The rest of the story: the microbiome and gastrointestinal infections

4. The microbiome and autoimmunity: a paradigm from the gut–liver axis

5. Gut microbiota and gastrointestinal health: current concepts and future directions

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Ongoing Developments in Targeting Clostridioides difficile Infection and Recurrence;Microorganisms;2024-06-15

2. Novel drug candidates against antibiotic-resistant microorganisms: A review;IRAN J BASIC MED SCI;2024

3. The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection–Associated Methicillin-Resistant Staphylococcus aureus;The Journal of Infectious Diseases;2023-12-26

4. Bifunctional antibiotic hybrids: A review of clinical candidates;Frontiers in Pharmacology;2023-06-12

5. Antibiotics in the clinical pipeline as of December 2022;The Journal of Antibiotics;2023-06-08